Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats
Authors:
- 12 December 2019
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 237 (3) , 855-867
Abstract
Rationale Kratom is proposed to exhibit therapeutic potential as an opium substitute, but little is known about its dependence-producing profile, particularly of its main psychoactive compound, mitragynine (MG). Objectives This study examined the dependence-producing effects of MG using operant-scheduled behaviour in rats and investigated the potential therapeutic effect of MG by comparing effects to buprenorphine in morphine-dependent rats using the same schedule-controlled behavioural task. Methods The effects of acutely administered MG and morphine were determined in rats trained to respond under fixed-ratio (FR) 10 schedule of food reinforcement. Next, the rats were administered MG and morphine twice daily for 14 consecutive days to determine if physiological dependence would develop by examining cessation of drug treatment and following antagonist-precipitated withdrawal. The study then examined the effects of MG substitution to suppress naloxone-precipitated morphine withdrawal effects on scheduled responding. Results Acute doses of MG did not produce dose-related decreases on FR schedules of responding compared to morphine. Unlike morphine, MG-treated rats showed no suppression of response rates following cessation of MG treatment. However, withdrawal effects were evident for MG after precipitation by either naloxone or SR141716A (rimonabant), similar to morphine-treated rats. MG in higher doses (10 and 30 mg/kg) attenuated the naloxone-precipitated morphine withdrawal effects while smaller doses of buprenorphine (0.3 and 1.0 mg/kg) were necessary to alleviate these effects. Conclusion The findings suggest that MG does not induce physiological dependence but can alleviate the physical symptoms associated with morphine withdrawal which represent the desired characteristics of novel pharmacotherapeutic interventions for managing opioid use disorder (OUD).Keywords
Funding Information
- Higher Education Centre of Excellence (HiCoE) special funding (311/CDADAH/4401009)
- USM Short Term Research Grant (304/CDADAH/6315105)
This publication has 56 references indexed in Scilit:
- Effects of an alkaloid-rich extract from Mitragyna speciosa leaves and fluoxetine on sleep profiles, EEG spectral frequency and ethanol withdrawal symptoms in ratsPhytomedicine, 2015
- Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional studyJournal of Ethnopharmacology, 2012
- Effects of imidazoline I2 receptor agonists and morphine on schedule-controlled responding in ratsPharmacology Biochemistry and Behavior, 2012
- Precipitated and conditioned withdrawal in morphine-treated ratsPsychopharmacology, 2010
- Morphine Deprivation Increases Self-Administration of the Fast- and Short-Acting μ-Opioid Receptor Agonist Remifentanil in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Self‐treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)Addiction, 2008
- The Use of Mitragynine speciosa (“Krathom”), an Addictive Plant, in ThailandSubstance Use & Misuse, 2007
- Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming testPsychopharmacology, 2001
- Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after Δ9-tetrahydrocannabinol withdrawalEuropean Journal of Pharmacology, 2000
- Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in ratsPsychopharmacology, 1990